Metoprolol succinate prices in the United States exhibited a mixed trend during the second quarter. In May, prices experienced a modest increase of 0.61% due to heightened end-user demand and concurrent inventory replenishment activities, creating a favorable market environment. However, the manufacturing PMI (Purchasing Managers Index) dipped to 48.4 in May, signaling a slowdown in the US manufacturing sector, which led to supply constraints among manufacturers and suppliers due to reduced business activity. Despite these challenges, strong consumer demand persisted, contributing to higher metoprolol succinate prices in May. Conversely, prices declined by 0.75% in June compared to May, primarily due to unexpectedly sluggish offtakes in end-user industries. Domestic suppliers maintained ample stock of Metoprolol Succinate, resulting in continuous price decreases in the domestic market. Additionally, the Federal Reserve’s implementation of high-interest rates reduced demand for metoprolol succinate, further supporting the downward price trend. Furthermore, the appreciation of the US dollar against the Chinese yuan in June stimulated imports into the US market, augmenting supply and exerting additional downward pressure on metoprolol succinate prices.
Metoprolol succinate prices in China displayed mixed trends throughout the second quarter. In May, prices increased by 0.78%, contrasting with April levels, primarily driven by sustained domestic demand and ongoing operational activity. China’s purchasing managers’ index (PMI) dropped to 48.8 in May from 49.2 in April, indicating a slowdown in factory activity. Despite this, manufacturers and market suppliers reduced inventories to meet strong market demand, resulting in higher metoprolol succinate prices. However, in June, metoprolol succinate prices decreased by 0.78% compared to May, mainly due to declining new orders and reduced consumer purchasing activity. The official manufacturing Purchasing Managers’ Index (PMI) increased to 49.0 in June from 48.8 in the previous month, suggesting a slowdown in manufacturing activity. This was accompanied by a decrease in production due to weak demand from end-users. Despite these factors, prices remained relatively low as market participants maintained sufficient inventory to meet existing market demand. Moreover, China’s exports fell by 12.4% in June, leading to increased availability of metoprolol succinate in the Chinese market, further supporting the downward price trend.
Get Real Time Prices of Metoprolol Succinate: https://www.chemanalyst.com/Pricing-data/metoprolol-succinate-1455
Metoprolol Succinate prices in Germany displayed a mixed trend throughout the second quarter. Prices experienced a slight increase of 0.57% in May compared to April, driven by limited stockpiles among traders and suppliers, along with increased demand from end-user industries. However, the manufacturing Purchasing Managers’ Index (PMI) for Germany fell to 43.2 in May from 44.5 in April, indicating weaker business activity and lower inventories among market participants, leading to shipment delays to meet demand and subsequently higher Metoprolol Succinate prices. In June, the German economy faced rising inflation and an interest rate hike by the European Central Bank, resulting in higher food and energy prices. This led to increased living costs and reduced consumer purchasing activity, contributing to the downward trend in Metoprolol Succinate prices. Additionally, the appreciation of the Euro against the US dollar in June made imports cheaper and bolstered the supply of metoprolol succinate in the German market, exerting further downward pressure on prices.
GmbH – S-01, 2.floor, Subbelrather Straße,
15a Cologne, 50823, Germany